Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
72.83
+0.05 (0.07%)
At close: Nov 9, 2026, 4:00 PM EST
72.85
+0.02 (0.03%)
Pre-market: Nov 10, 2026, 7:37 AM EST
Bio-Techne Market Cap
Bio-Techne has a market cap or net worth of $11.44 billion as of November 9, 2026. It is the 1,955th most valuable company in the world and the 700th biggest in the United States. Its market cap has increased by 27.90% in one year.
Market Cap
11.44B
Enterprise Value
11.38B
1-Year Change
27.90%
Global Rank
Country Rank
#700 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Bio-Techne's market cap has increased from $355.80M to $11.44B, an increase of 3,115.55%. That is a compound annual growth rate of 13.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 11.44B | 24.86% |
| Dec 31, 2025 | 9.16B | -19.94% |
| Dec 31, 2024 | 11.45B | -6.21% |
| Dec 29, 2023 | 12.20B | -6.20% |
| Dec 30, 2022 | 13.01B | -36.00% |
| Dec 31, 2021 | 20.33B | 65.81% |
| Dec 31, 2020 | 12.26B | 46.55% |
| Dec 31, 2019 | 8.37B | 53.07% |
| Dec 31, 2018 | 5.47B | 12.61% |
| Dec 29, 2017 | 4.85B | 26.50% |
| Dec 30, 2016 | 3.84B | 14.62% |
| Dec 31, 2015 | 3.35B | -2.30% |
| Dec 31, 2014 | 3.43B | -1.84% |
| Dec 31, 2013 | 3.49B | 38.67% |
| Dec 31, 2012 | 2.52B | -0.35% |
| Dec 30, 2011 | 2.53B | 3.71% |
| Dec 31, 2010 | 2.44B | -4.63% |
| Dec 31, 2009 | 2.55B | 4.09% |
| Dec 31, 2008 | 2.45B | -6.00% |
| Dec 31, 2007 | 2.61B | 19.52% |
| Dec 29, 2006 | 2.18B | 0.16% |
| Dec 30, 2005 | 2.18B | 35.65% |
| Dec 31, 2004 | 1.61B | 3.50% |
| Dec 31, 2003 | 1.55B | 31.15% |
| Dec 31, 2002 | 1.18B | -22.59% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 15.07B |
| BridgeBio Pharma | 14.47B |
| Summit Therapeutics | 13.06B |
| Halozyme Therapeutics | 11.81B |
| Kymera Therapeutics | 11.25B |
| BioMarin Pharmaceutical | 10.85B |
| Vaxcyte | 10.11B |
| Spyre Therapeutics | 9.86B |